Spectral Imaging Patents: Top Companies & Filing Trends 2026
- 58.9% concentration. The top 5 assignees hold 391 of 664 records in scope — filing here means competing directly with entrenched CT vendors, not carving out open ground.
- 2017 was the peak. Filings hit 75 that year and 2021-to-2024 volume fell 41% (49 to 29); because publication lags filing by about 18 months, 2025-2026 figures are still filling in and should not be read as a slowdown yet.
- A61B and G06T dominate. 62.3% of records sit in diagnosis/surgery claims and 38.6% in image-processing claims, while AI-model classes (G06N, 5.4%) and healthcare informatics (G16H, 4.2%) remain comparatively thin.
Filing growth compares 2021 (49 records) with 2024 (29) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 664 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
Spectral computed tomography and material decomposition patents describe how a CT system separates tissue and contrast signal by energy rather than density alone — virtual monoenergetic images, dual-energy acquisition, and the calibration routines that turn raw spectral data into iodine maps or basis-material images. This landscape covers 664 published records filed between 2015 and mid-2026, spanning claims on acquisition hardware, reconstruction algorithms, and the clinical-value metrics used to validate them.
The dataset draws on documents where the title or abstract references material decomposition, spectral CT, or virtual monoenergetic imaging, combined with claims language on iodine quantification accuracy, noise amplification, calibration, or clinical value. That combination captures both the imaging-physics side of the field and the diagnostic-accuracy side that determines whether a technique reaches the clinic.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 664 records: how filing volume moved year over year, and which IPC subclasses carry the claim density.
Filing activity peaked in 2017
Volume ran high through the late 2010s, reaching 75 records in 2017, then eased through the early 2020s — 2021's 49 records fell to 29 by 2024, a 41% decline. The last one to two years in any such series are undercounted because publication trails filing by roughly 18 months, so treat 2025 and 2026 as incomplete rather than as evidence of a cooling field.
Claims cluster in diagnosis and image processing
A61B (diagnosis and surgery) appears in 62.3% of records and G06T (image data processing) in 38.6%, confirming that most claim activity sits at the clinical-application and reconstruction-algorithm layers rather than at raw detector hardware. G01N and G01T, each near 14-15%, cover material-analysis and radiation-measurement claims; G06N (AI models, 5.4%), G06K (data recognition, 5.3%) and G16H (healthcare informatics, 4.2%) are comparatively lightly claimed, and H05G (X-ray technique) sits lowest at 3.2%.
Shares are the percentage of the 664 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Spectral Imaging and Material Decomposition with Eureka
This page is one run against one query. Ask Eureka your own question about spectral imaging and material decomposition and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited and most-recent filings
Hybrid models for spectral computed tomography material decomposition
A computer-implemented method for performing material decomposition includes acquiring, via a processing system including one or more processors, spectral computed tomography (CT) scan data. The method utilizes a hybrid model in conjunction with an optimization-based technique or a non-iterative inverse mapping to generate spectral CT basis material maps from the spectral CT scan data, wherein the hybrid model includes both calibration-data terms and physics-based terms.Filed by GE Precision Healthcare, this record pairs a physics-based calibration term with a learned inverse mapping — a hybrid structure that sits squarely between the field's two dominant approaches rather than picking one.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20050084069A1 | Methods and apparatus for identification and imaging of specific materials | 99 |
| 2 | US7298812B2 | Image-based material decomposition | 95 |
| 3 | US20040184574A1 | Method and apparatus for generating a density map using dual-energy CT | 87 |
| 4 | US20070237288A1 | Image-based material decomposition | 78 |
| 5 | US20110106072A1 | Low-Corrosion Electrode for Treating Tissue | 65 |
| 6 | US20160324499A1 | Methods and systems for metal artifact reduction in spectral CT imaging | 62 |
| 7 | US6987833B2 | Methods and apparatus for identification and imaging of specific materials | 59 |
| 8 | US20230011644A1 | X-ray imaging system | 56 |
| 9 | US20130251097A1 | Method and system for spectral computed tomography (CT) with sparse photon counting detectors | 56 |
| 10 | US20080260094A1 | Method and Apparatus for Spectral Computed Tomography | 54 |
Citation counts favour older documents that have had more time to accumulate references inside the searched corpus — read them as a signal of influence on the field's early framing, not as a ranking of current technical importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three patterns worth acting on before drafting claims in this space.
The top of the field is settled, not open
Five assignees hold 391 of the 664 records in scope. A new entrant filing broad material-decomposition claims is filing into territory already covered by incumbent CT manufacturers and their long-running families, not into a gap.
Complete-year volume has cooled from its 2021 level
The last fully countable comparison — 2021's 49 records against 2024's 29 — shows a real decline, though the earlier 2017 peak of 75 records suggests the field has already been through one filing wave. Years after 2024 are still filling in and should not be read alongside this figure.
Clinical-application claims outnumber hardware claims
A61B (diagnosis and surgery) and G06T (image processing) together dominate the classification mix, while G06N-classed AI-model claims sit at just 5.4% of records — a smaller footprint than the volume of spectral-CT machine-learning literature might suggest.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to spectral imaging and material decomposition, with the prior art for and against each one.
Who holds the claim space
The ranked leaders reflect a small group of CT-system manufacturers and one academic medical centre, with a long tail of single- or few-filing entrants behind them.
One assignee well ahead of the field
The top-ranked assignee holds 222 records, roughly a third of everything in scope — a scale gap that puts distance between the leader and even the rest of the top 5, where fifth place holds 29.
Recent-year filings have gone quiet across the leaderboard
Several of the largest historical filers, including entities tied to Philips, GE and Mayo Foundation, show zero filings in the latest tracked year and year-over-year drops of -100% where a prior-year baseline exists. Given the ~18-month publication lag, this reads as a reporting gap for the newest filings rather than a confirmed stop.
The top 10 leaves little room below it
Ten assignees account for 481 of the 664 records in scope. Below that line, filing activity fragments into single-digit and single-filing entrants, several of them academic bodies rather than manufacturers.
| Assignee | Recent year | YoY |
|---|---|---|
| Koninklijke Philips N.V. | 0 | -100% |
| General Electric Company | 0 | — |
| GE Precision Healthcare LLC | 0 | -100% |
| Canon Medical Systems Corporation | 0 | — |
| Siemens Healthineers AG | 0 | — |
| Mayo Foundation for Medical Education and Research | 0 | -100% |
| Toshiba Medical Systems Corporation | 0 | — |
| Toshiba Corporation | 0 | — |
Where to take this next
The dataset points to specific next steps depending on whether the goal is freedom-to-operate, whitespace filing, or competitive tracking.
Run a freedom-to-operate check against the top 5
With 58.9% of records held by five assignees, any new filing on core material-decomposition or virtual-monoenergetic claims should be checked against their families before drafting.
Check claims in EurekaScope the under-claimed branches
G06N, G06K and G16H classifications sit well below A61B and G06T in share of records, pointing to informatics and AI-calibration angles that remain comparatively open.
Explore whitespace in EurekaTrack leader momentum past 2024
Because publication lags filing by about 18 months, the apparent drop-off in 2025-2026 filings from major assignees needs re-checking once later data fills in.
Set up monitoring in EurekaCommon questions about this landscape
The ranking covers 100 assignees across 664 records, and it is heavily front-loaded: the leading assignee alone holds 222 records, and the top 5 combined account for 391 records, or 58.9% of everything in scope. The leaders are the CT-system manufacturers you would expect — Philips, GE, Canon, Siemens Healthineers and their group entities — plus Mayo Foundation as the one academic-medical presence in the top tier. Below the top 10, which together hold 72.4% of records, filing activity fragments quickly into a long tail of few- or single-filing entrants.
Filing volume peaked at 75 records in 2017 and has since eased; the clearest complete-year comparison shows 2021's 49 records falling to 29 by 2024, a 41% decline. That is a real trend for years that are fully counted, but publication typically lags filing by around 18 months, so 2025 and 2026 figures in any such dataset are still incomplete and should not yet be read as confirmation of further decline. A fair read is that the field has already been through a filing wave and cooled from its peak, not that it has stopped.
Material decomposition is the process of using spectral (multi-energy) CT data to separate an image into component materials — commonly iodine contrast versus soft tissue or bone — rather than producing a single density-based grayscale image. Patent claims in this space cover the acquisition method (how dual- or multi-energy data is captured), the decomposition algorithm itself, and calibration routines that keep iodine quantification accurate and control noise amplification. In this dataset, 62.3% of records carry an A61B (diagnosis and surgery) classification and 38.6% carry G06T (image processing), showing that most claims sit at the clinical-application and algorithmic layers.
Relative to the field's dominant A61B and G06T claim volume, classifications tied to AI-model-based calibration (G06N, 5.4% of records), data recognition and presentation (G06K, 5.3%), healthcare informatics integration (G16H, 4.2%) and X-ray source technique (H05G, 3.2%) are comparatively thin. That does not mean these areas are unclaimed, but claim density there is much lower than in core decomposition and image-processing claims, which is where a narrower, well-drafted first claim has more room to stand on its own prior art rather than colliding with incumbent families.
The most-cited records in this dataset date back to the mid-2000s and 2010s, including filings on identification and imaging of specific materials and image-based material decomposition methods, some cited over 90 times. High citation counts reflect the fact that older documents inside a searched corpus have simply had more time to accumulate references, so they signal historical influence on how the field's claims were framed rather than current technical importance. A newer, less-cited filing can still be more relevant to a present-day freedom-to-operate check.
Research Spectral Imaging and Material Decomposition in depth with Eureka
Go past this page: query the whole spectral imaging and material decomposition corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.